Clinical Trial: A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07797322) titled 'A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function' on Aug. 26.

Brief Summary: The purpose of this trial is to assess any potential exposure increases of PKN605 in participants with reduced renal function to support decisions on participant eligibility and dosing in subsequent clinical trials of PKN605.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Participants With Moderate and Severe Renal Impairment and Healthy Participants

Intervention: DRUG: PKN605

PKN605 orally as a t...